Institutional investors lightened up their holdings of MLNT shares during the quarter ended September 2017 as they sold a net $533.6 thousand shares. Additionally, the 0.00% of shares outstanding that remains in their hands is below average for companies in the Pharmaceuticals: Other industry and highlights that this company is not an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PANAGORA ASSET MANAGEMENT, INC. Bought 513.1 Thousand shares of Melinta Therapeutics, Inc...